Skip to main content
Press Releases

Austrian MedTech Biome Diagnostics goes NASDAQ

By June 27, 2023July 10th, 2023No Comments

Biome Diagnostics receives multiple awards for excellence, and advertising space at NASDAQ Tower in Times Square, New York

Vienna, June 26, 2023 – Biome Diagnostics, a leading Austrian company in the field of medical microbiome diagnostics, has won several awards for outstanding performance at many internationally renowned events. The awards highlight the company’s commitment and innovation in developing groundbreaking oncology and preventive solutions in the microbiome field.

At the EIT Health Catapult Finals, held at the prestigious Bits & Pretzels HealthTech conference in Munich, Biome Diagnostics was awarded 2nd place in the MedTech category. The Austrian MedTech not only won a cash prize but also several industry awards. Furthermore, the audience recognized the company’s groundbreaking innovations by rewarding it with the coveted Alex Casta Audience Award. Biome Diagnostics is thus now able to present its logo at the NASDAQ Tower in Times Square in New York, where it is seen by millions of people worldwide.

Biome Diagnostics’ international strength was also recognized nationally at the Austrian Chamber of Commerce (WKÖ) Export Day with the “Born Global Champion 2023” Award. This award recognizes the outstanding achievements of Austrian startups that are successful in international markets from their inception, offer innovative products and services, and show rapid growth. Nikolaus Gasche, Co-Founder and Managing Director of Biome Diagnostics, on the successes at Bits & Pretzels HealthTech: “Last week was unique and overwhelming. To be able to perform as a finalist of the EIT Health Catapult in front of thousands of visitors and to reach 2nd place in the process means a lot to us. I would especially like to thank the audience who voted us as the most innovative company and thus awarded us with the Alex Casta Audience Award. It is a special milestone to be able to show Biome Diagnostics in front of millions of people in Times Square, sharing the vision of world-class microbiome diagnostics. This is the only way to advance personalized medicine.”

Barbara Sladek, PhD, MBA, Co-Founder and Managing Director of Biome Diagnostics, on the Born Global Champions Award: “We are incredibly proud of the recognition Biome Diagnostics received last week. The Born Global Champions award is a validation of our ongoing efforts to develop innovative microbiome solutions on an international scale that have a positive impact on healthcare. I am very grateful to our supporters and partners for getting us to this point.”